OPCML and neoplasm: To localize the clinical mutations on the three-dimensional structure of OPCML and to gain insights into their role in the tumor suppressor mechanism(s) we crystallized soluble recombinant OPCML (residues 36–316) and determined its structure using a combined single-wavelength X-ray anomalous dispersion/molecular replacement approach (Table 1).